Bausch Health's stock takes a hit following board changes and ongoing market pressures.
In the latest trading session, Bausch Health Companies Inc (BHC.TO) saw its stock price drop by 2.58%, closing at CA$6.81. This decline reflects broader concerns among investors about the company's leadership stability and market performance.
Advertisement
Get up to $2,000 cash back
Open and fund a new Qtrade account with promo code SPRING26. Offer ends July 31, 2026.
Bausch Health Companies Inc
BHC.TO
BHC.TO
Bausch Health Companies Inc
WealthAwesomeMarket cap
$2.53B
52W high
$11.97
52W low
$6.45
1W change
-3.92%
Beta
0.42
Analyst Price Targets
Based on analyst covering BHC
Wall Street analysts forecast BHC stock price to rise 6.0% over the next 12 months.
Consensus
Moderately BullishBased on avg. target vs last close (formal rating unavailable for Canadian listings)
Avg. Target
C$7.01
+6.0% Upside
Current Price
C$6.61
Last close
Analyst ratings and price targets are updated periodically. Not financial advice.
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on BHC's historical volatility
30-Day Vol
45.9%
Annualized
90-Day Vol
41.4%
Annualized
Trend (90d)
-50.0%
Annualized drift
90d Mean
C$5.53
Expected price
| Horizon | Expected | 68% Range (1ฯ) |
|---|---|---|
| 30 trading days | C$6.23 | C$5.32 โ C$7.30 |
| 60 trading days | C$5.87 | C$4.69 โ C$7.34 |
| 90 trading days | C$5.53 | C$4.20 โ C$7.27 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ยฑ1ฯ, 95% band = ยฑ2ฯ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
Investor takeaway: Investors should be cautious as Bausch Health navigates leadership changes and market challenges, which could impact future performance.
Bausch Health's Market Cap at CA$2.57 Billion
Despite a significant market cap, Bausch Health's recent performance raises questions about its financial health and future growth prospects.
Bull case
If Bausch Health can stabilize its leadership and refocus on its core business areas, there may be potential for recovery in stock performance. A solid plan to strengthen its operations could lead to renewed investor confidence and a rebound in share value.
Bear case
Continued uncertainty around executive leadership and market volatility could lead to further declines in Bausch Health's stock price. If these challenges persist, investors might see a prolonged period of instability and risk.
Leadership Changes Impacting Investor Confidence
The resignation of Michael Goettler from Bausch Health's Board of Directors has raised eyebrows among investors. While the company stated that his departure was not due to any disagreements, the timing has coincided with a drop in stock value, leading to speculation about the company's future direction. For more details, check out our BHC.TO stock page.
Market Pressures and Financial Health
Bausch Health's stock performance is not only influenced by leadership changes but also by broader market pressures. With a profit margin of -11.47%, the company faces significant challenges in turning around its financial health. Investors should remain vigilant as they monitor future earnings reports and market conditions. For an in-depth look at Bausch Health's financial metrics, visit our BHC.TO stock page.
Advertisement
